Press releases

23
Jan 2017
21:30 E.S.T.

Cellectis Studies Safety in New CAR Architecture Controlling CAR T-Cell Functions

Read more
23
Jan 2017
21:30 E.S.T.

Four Prominent Physicians to Join Cellectis Clinical Advisory Board

Read more
4
Jan 2017
21:30 E.S.T.

Cellectis to Present at the 35th Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2017 at 8:00am PT

Read more
3
Jan 2017
21:30 E.S.T.

Cellectis Submits IND Application for UCART123, an Allogeneic Gene Edited CAR T-Cell Product Candidate, in AML and BPDCN

Read more
16
Dec 2016
21:30 E.S.T.

Cellectis Announces Conference Call To Discuss Recent Recombinant DNA Advisory Committee (RAC) Meeting

Read more
15
Dec 2016
21:30 E.S.T.

Cellectis Announces Recombinant DNA Advisory Committee’s (RAC) Unanimous Approval of UCART123 Phase 1 Study Protocols in AML and BPDCN

Read more
22
Nov 2016
21:30 E.S.T.

Cellectis Reports Financial Results for 3rd Quarter and First Nine Months 2016

Read more
21
Nov 2016
21:30 E.S.T.

Cellectis to Participate in Oppenheimer Life Sciences Summit, NY & in Piper Jaffray 28th Annual Health Care Conference, NY

Read more
15
Nov 2016
21:30 E.S.T.

Cellectis Announces Successful cGMP Manufacturing for Second Product Candidate: UCART123

Read more
31
Oct 2016
20:30 E.S.T.

Cellectis Hosts World’s First Gene Edited Dinner in NYC

Read more

Press contacts

For more information on any story, or for press enquiries, get in touch with our communication team

CONTACT US